TERN
Terns Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +18.2% ·
share flow +1.5% ·
net new positions +15.4%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q1 2026 | 105 | +14 | 70.88M | $3.72B | +22 | −9 |
| Q4 2025 | 91 | +4 | 71.76M | $2.90B | +5 | — |
| Q3 2025 | 16 | 0 | 30.56M | $229.52M | — | — |
| Q2 2025 | 13 | 0 | 20.60M | $76.83M | +2 | −2 |
| Q1 2025 | 10 | -3 | 10.19M | $28.12M | — | −3 |
| Q4 2024 | 13 | +2 | 13.10M | $72.60M | +2 | — |
| Q3 2024 | 10 | -1 | 11.63M | $97.00M | — | −1 |
| Q2 2024 | 11 | — | 7.84M | $53.39M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 3.27M | -11.0% | $18.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Millennium Management ✦ | 1.61M | +2.0% | $8.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.52M | +25.6% | $8.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.52M | +25.6% | $8.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 1.50M | +1.9% | $8.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.50M | +1.9% | $8.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passive) | 1.29M | — | $7.13M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 1.25M | -53.8% | $6.94M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 849.39K | New | $4.71M | 0.0% | New | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 803.34K | +666.9% | $4.45M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 803.34K | +666.9% | $4.45M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 623.13K | +29.9% | $3.45M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 222.51K | +0.2% | $1.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 222.51K | +0.2% | $1.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 94.69K | -34.4% | $524,577 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 57.34K | +53.0% | $317,669 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 57.34K | +53.0% | $317,669 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 16.87K | New | $93,449 | 0.0% | New | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 16.87K | New | $93,449 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Norges Bank | $4.71M | 0.0% |
| AQR Capital Management | $93,449 | 0.0% |
| AQR Capital Management | $93,449 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 314 holders, 121.84M shares, $6.09B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.